Quoin Pharmaceuticals Ltd. - American Depositary Shares (QNRX) closed at $3.70 on November 13, 2026, down 1.3% from the previous close, on volume of 15,987 shares (30-day average 25,380).
Data as of November 13, 2026.
Quoin Pharmaceuticals Shareholders Approve Beneficial Ownership Limit Changes
TipRanks (Thu, 12-Nov 6:04 PM ET)
Canaccord Genuity Keeps Their Buy Rating on Quoin Pharmaceuticals (QNRX)
TipRanks (Mon, 9-Nov 7:56 AM ET)
Globe Newswire (Fri, 6-Nov 8:30 AM ET)
Quoin Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Globe Newswire (Thu, 5-Nov 8:30 AM ET)
Globe Newswire (Thu, 29-Oct 8:30 AM ET)
Globe Newswire (Tue, 20-Oct 6:30 AM ET)
Globe Newswire (Wed, 14-Oct 6:30 AM ET)
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Globe Newswire (Tue, 6-Oct 6:30 AM ET)
Globe Newswire (Tue, 22-Sep 8:30 AM ET)
Globe Newswire (Thu, 10-Sep 8:30 AM ET)
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.
As of November 13, 2026, QNRX stock price declined to $3.70 with 15,987 million shares trading.
QNRX has a beta of 1.08, meaning it tends to be more sensitive to market movements. QNRX has a correlation of 0.01 to the broad based SPY ETF.
QNRX has a market cap of $17.78 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, QNRX traded as high as $216.30 and as low as $3.25.
QNRX has underperformed the market in the last year with a price return of -72.4% while the SPY ETF gained +13.4%. QNRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.8% and -18.5%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
QNRX support price is $3.50 and resistance is $4.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.
